Article Text

Download PDFPDF
Lack of relationship of AT1001 to zonulin and prehaptoglobin-2: clinical implications

Statistics from


  • LMS and FK contributed equally.

  • Contributors LS and FK are equal contributors to this article.

  • Funding LMS is funded in part by the Stiftelsen KG Jebsen (SKGJ-MED-017) and a grant from the South-Eastern Norway Regional Health Authority (project #2020027). FK is funded in part by the collaboration project TIMID (LSHM18057-SGF) financed by the PPP allowance made available by Top Sector Life Sciences and Health to Samenwerkende Gezondheidsfondsen (SGF).

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.